Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | PPARG | P37231 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | RXRA | P19793 | 1/20 | 0.41 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.41 |
| ▸ | TERT | O14746 | 3/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.40 |
| ▸ | PPARD | Q03181 | 3/20 | 0.40 |
| ▸ | PPARA | Q07869 | 3/20 | 0.40 |
| ▸ | TOP1 | P11387 | 3/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | BLM | P54132 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | FABP4 | P15090 | 2/20 | 0.40 |
| ▸ | F7 | P08709 | 2/20 | 0.40 |
| ▸ | F3 | P13726 | 2/20 | 0.40 |
| ▸ | FAAH | O00519 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1784552 | 1.00 | ALDH1A1 (0.45) | ALDH1A1PPARGMAPTCYP19A1FFAR1 | |
| SCHEMBL11136992 | 1.00 | ALDH1A1 (0.45) | ALDH1A1PPARGMAPTCYP19A1FFAR1 | |
| SCHEMBL12261542 | 0.93 | PPARG (0.52) | ALDH1A1PPARGMAPTCYP19A1FFAR1 | |
| SCHEMBL11009268 | 0.89 | ALDH1A1 (0.56) | ALDH1A1PPARGMAPTCYP19A1FFAR1 | |
| SCHEMBL11009265 | 0.89 | ALDH1A1 (0.56) | ALDH1A1PPARGMAPTCYP19A1FFAR1 | |
| SCHEMBL1785025 | 0.85 | F7 (0.57) | ALDH1A1PPARGMAPTCYP19A1FFAR1 | |
| SCHEMBL1785023 | 0.85 | F7 (0.57) | ALDH1A1PPARGMAPTCYP19A1FFAR1 | |
| SCHEMBL1905069 | 0.84 | — | — | |
| SCHEMBL9651209 | 0.84 | — | — | |
| SCHEMBL1905071 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2948001-B9 | IMPROVED MICROALGAL FLOUR | CORBION BIOTECH INC (US) | 2022-03-23 | — | — | EP | claimed |
| EP-2948001-B1 | IMPROVED MICROALGAL FLOUR | CORBION BIOTECH INC (US) | 2021-09-29 | — | — | EP | claimed |
| US-20250241356-A1 | ORAL COMPOSITION COMPRISING RECEPTOR MODULATOR | DANIEL MICHAEL S (US) | 2025-07-31 | — | — | US | disclosed |
| EP-4543229-A1 | ORAL COMPOSITION COMPRISING A RECEPTOR MODULATOR | Nicoventures Trading Limited (GB) | 2025-04-30 | — | — | EP | disclosed |
| WO-2023248187-A1 | ORAL COMPOSITION COMPRISING A RECEPTOR MODULATOR | Nicoventures Trading Limited (GB) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023057401-A1 | METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS | MERCK PATENT GMBH (DE) | 2023-04-13 | — | — | WO | disclosed |
| CN-108473484-B | Compounds useful as TRPM8 modulators | 弗门尼舍公司 | 2021-06-29 | — | — | CN | disclosed |
| US-8632792-B2 | Cooling sensation agent composition and sensory stimulation agent composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-01-21 | — | — | US | disclosed |
| US-20110117147-A1 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-05-19 | — | — | US | disclosed |
| WO-2009123355-A2 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-10-08 | — | — | WO | disclosed |
| EP-0775111-B1 | STABLE VITAMIN A | PROCTER & GAMBLE (US) | 2001-08-29 | — | — | EP | disclosed |
| US-5648091-A | TOCOPHEROL | THE PROCTOR & GAMBLE COMPANY (US) | 1997-07-15 | — | — | US | disclosed |
| EP-0775111-A1 | STABLE VITAMIN A | THE PROCTER & GAMBLE COMPANY (US) | 1997-05-28 | — | — | EP | disclosed |
| WO-1996004243-A1 | STABLE VITAMIN A | THE PROCTER & GAMBLE COMPANY (US) | 1996-02-15 | — | — | WO | disclosed |
| US-5426248-A | Purified vitamin A which has been deodorized and degassed by controlled vacuum heating in absence of light and sparging with inert gas, for foods | THE PROCTER & GAMBLE COMPANY (US) | 1995-06-20 | — | — | US | disclosed |
| EP-0022955-A1 | Process for the production of higher unsaturated ketones | BASF Aktiengesellschaft (DE) | 1981-01-28 | — | — | EP | disclosed |
| US-3953377-A | Ethyl-2-trans-4-cis undecadienoate, ethyl-2-trans-4-cis dodecadienoate and ethyl-2-decadienoate perfume compositions | FIRMENICH S.A. (CH) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110117147-A1 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TRPA1, HRH1, HRH2 | ALDH1A1 520/4885PPARG 1977/4885MAPT 906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.